Compulsive policy on drug prices hampers the pharmaceutical industry

In its recent executives' meeting, the Korean Pharmaceutical Manufacturers Association (KPMA) has demanded that the government should promote to foster better management atmosphere of the domestic pharmaceutical industry towards R&D new drug projects, instead of waivering excessive control on the insurance-covered drug prices

The KPMA says that there is an urgent need for the pharmaceutical ...